Conditions: Chronic Noncancer Pain
Keywords: Chronic noncancer pain oxycodone naltrexone
Enrollment: 395
Healthy volunteers: no

Brief summary:
The study will provide information to assess the benefits versus risks of extended exposure to oxycodone HCl and naltrexone HCl extended-release capsules in a chronic noncancer pain population.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: oxycodone HCl and naltrexone HCl extended-release capsules
Intervention descriptions: intervention 1: Daily dose range of 20 mg to 160 mg of the oxycodone component in a 24 hour time interval, administered twice daily approximately 12 hours apart (At the discretion of the Investigator, oxycodone HCl and naltrexone HCl extended-release capsules may be administered once daily, at 24 hour intervals.)

Protocol document: